Search

everythinglearnresearchcommunity

for

Search:↓

Targeted cancer therapies often cause serious skin problems that need careful management.

Electric pulse treatments for breast cancer show promise in being safer and more effective, with fewer side effects.

Diphencyprone treatment increases CD8 lymphocytes in the scalp, which is associated with hair regrowth in alopecia areata patients.

The topical solution increased hair count but wasn't significantly better than placebo in other measures.

Hair loss can occur as a side effect of certain breast cancer treatments, but minoxidil can help regrow hair.

A combination of desogestrel and ethinyl oestradiol effectively reduces hair growth in hirsute women.

Cyproterone acetate therapy improved hair loss and reduced testosterone levels in a menopausal woman.

Tofacitinib helped regrow hair in a woman with alopecia areata.

The scaffold effectively prevents melanoma relapse and aids wound healing.

EGFR inhibitors in breast cancer treatment can cause serious skin issues affecting patient quality of life.

A boy with chromosome 13q deletion syndrome developed eye cancer, a woman with breast cancer lost vision due to a rare side-effect of her treatment, a man's vision worsened after using a hair loss drug, and two rare disorders were discussed. Optical Coherence Tomography is useful for diagnosing and monitoring these conditions.

Patients with advanced breast cancer prioritize quality of life, overall survival, and progression-free survival in treatment decisions.

Androgen Deprivation Therapy for prostate cancer often reduces sexual function but intermittent therapy may be more tolerable.

Older ovarian cancer patients live longer and tolerate weekly chemotherapy better than three-weekly treatments.

Tofacitinib effectively treated severe alopecia areata in a 14-year-old girl.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

Hair loss is a common side effect of hormone treatments for cancer.

Long-term treatment with palbociclib plus letrozole maintains quality of life in certain breast cancer patients.

Hair regrowth treatments had modest benefits for patients with long-term hair loss after chemotherapy.

Hedgehog pathway inhibitors used for skin cancer can cause significant hair loss, which may improve after stopping the medication.

DPCP is effective for treating severe alopecia areata, but relapse is common.

Low dose oral minoxidil helped treat long-term hair loss caused by chemotherapy in 15 patients.

Epidermal growth factor helps hair recover after chemotherapy.

Suppressing eIF4E can prevent hair loss from chemotherapy.

Anti-PD-L1 immunotherapy can cause hair loss and unexpected hair color change, but treatment can restore hair growth and color.

Cyproterone acetate with estradiol improved women's self-confidence and emotional well-being without a difference between oral or transdermal methods, but younger women preferred the oral method.

Direct-to-consumer teledermatology effectively treats male hair loss but may increase drug costs and requires monitoring for side effects.

More extensive trials are needed to understand tofacitinib's role in treating severe hair loss.